Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTA) Gross Margin (2021 - 2025)

Strata Critical Medical (SRTA) has disclosed Gross Margin for 5 consecutive years, with 17.47% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 369.0% to 17.47% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 38.93% through Dec 2025, up 1860.0% year-over-year, with the annual reading at 20.86% for FY2025, 71.0% up from the prior year.
  • Gross Margin for Q4 2025 was 17.47% at Strata Critical Medical, down from 23.56% in the prior quarter.
  • The five-year high for Gross Margin was 97.36% in Q1 2025, with the low at 268.66% in Q4 2023.
  • Average Gross Margin over 5 years is 27.58%, with a median of 21.9% recorded in 2024.
  • The sharpest move saw Gross Margin plummeted -28171bps in 2023, then surged 28244bps in 2024.
  • Over 5 years, Gross Margin stood at 16.01% in 2021, then fell by -19bps to 13.05% in 2022, then plummeted by -2159bps to 268.66% in 2023, then soared by 105bps to 13.78% in 2024, then rose by 27bps to 17.47% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 17.47%, 23.56%, and 25.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.